CN111315878B - 经修饰l-天冬酰胺酶 - Google Patents

经修饰l-天冬酰胺酶 Download PDF

Info

Publication number
CN111315878B
CN111315878B CN201880054251.4A CN201880054251A CN111315878B CN 111315878 B CN111315878 B CN 111315878B CN 201880054251 A CN201880054251 A CN 201880054251A CN 111315878 B CN111315878 B CN 111315878B
Authority
CN
China
Prior art keywords
asparaginase
ala pro
pro ala
amino acid
recombinant protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201880054251.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN111315878A (zh
Inventor
L·弗雷德里希
A·奥德内尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jazz Pharmaceuticals Ireland Ltd
Original Assignee
Jazz Pharmaceuticals Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP17177237.9A external-priority patent/EP3418383A1/en
Priority claimed from US15/671,086 external-priority patent/US10174302B1/en
Application filed by Jazz Pharmaceuticals Ireland Ltd filed Critical Jazz Pharmaceuticals Ireland Ltd
Publication of CN111315878A publication Critical patent/CN111315878A/zh
Application granted granted Critical
Publication of CN111315878B publication Critical patent/CN111315878B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C12N9/82—Asparaginase (3.5.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
    • C12Y305/01001—Asparaginase (3.5.1.1)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CN201880054251.4A 2017-06-21 2018-06-21 经修饰l-天冬酰胺酶 Active CN111315878B (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201762523061P 2017-06-21 2017-06-21
EP17177237.9 2017-06-21
US62/523,061 2017-06-21
EP17177237.9A EP3418383A1 (en) 2017-06-21 2017-06-21 Modified l-asparaginase
US15/671,086 2017-08-07
US15/671,086 US10174302B1 (en) 2017-06-21 2017-08-07 Modified L-asparaginase
PCT/EP2018/066647 WO2018234492A1 (en) 2017-06-21 2018-06-21 L-ASPARAGINASE MODIFIED

Publications (2)

Publication Number Publication Date
CN111315878A CN111315878A (zh) 2020-06-19
CN111315878B true CN111315878B (zh) 2024-04-26

Family

ID=64737515

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880054251.4A Active CN111315878B (zh) 2017-06-21 2018-06-21 经修饰l-天冬酰胺酶

Country Status (15)

Country Link
EP (2) EP3642340B1 (cg-RX-API-DMAC7.html)
JP (2) JP7808424B2 (cg-RX-API-DMAC7.html)
KR (1) KR102727396B1 (cg-RX-API-DMAC7.html)
CN (1) CN111315878B (cg-RX-API-DMAC7.html)
AU (1) AU2018287145B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019027479A2 (cg-RX-API-DMAC7.html)
CA (1) CA3068100A1 (cg-RX-API-DMAC7.html)
DK (1) DK3642340T3 (cg-RX-API-DMAC7.html)
ES (1) ES2979314T3 (cg-RX-API-DMAC7.html)
FI (1) FI3642340T3 (cg-RX-API-DMAC7.html)
IL (1) IL271504B2 (cg-RX-API-DMAC7.html)
MX (2) MX2019015502A (cg-RX-API-DMAC7.html)
SA (2) SA522433360B1 (cg-RX-API-DMAC7.html)
SG (1) SG11201912625QA (cg-RX-API-DMAC7.html)
WO (1) WO2018234492A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7065772B2 (ja) 2015-12-22 2022-05-12 エクスエル‐プロテイン ゲーエムベーハー 低反復性ヌクレオチド配列を有する、プロリンおよびアラニン残基が豊富な反復性アミノ酸配列をコードする核酸
US12478604B1 (en) 2016-07-22 2025-11-25 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US12186296B1 (en) 2016-07-22 2025-01-07 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
ES2979314T3 (es) * 2017-06-21 2024-09-25 Jazz Pharmaceuticals Ireland Ltd L-asparaginasa modificada
EP3713595A1 (en) * 2017-11-22 2020-09-30 Merz Pharma GmbH & Co. KGaA Novel recombinant botulinum toxin with increased duration of effect
BR112021013766A2 (pt) 2019-03-01 2021-09-21 Flamel Ireland Limited Composições de gama-hidroxibutirato com farmacocinética melhorada no estado alimentado
CA3156066A1 (en) * 2019-10-25 2021-04-29 Mi Rim Choi Recombinant l-asparaginase
KR20230125179A (ko) * 2020-12-23 2023-08-29 재즈 파마슈티칼즈 아일랜드 리미티드 전하-차폐 융합 단백질의 정제 방법
WO2022211829A1 (en) 2021-03-30 2022-10-06 Jazz Pharmaceuticals Ireland Ltd. Dosing of recombinant l-asparaginase
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
US20260007728A1 (en) 2022-07-14 2026-01-08 Jazz Pharmaceuticals Ireland Ltd. Combination therapies involving l-asparaginase

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0211639A2 (en) * 1985-08-06 1987-02-25 The Public Health Laboratory Service Board Production of L-asparaginase
CN101641439A (zh) * 2007-03-09 2010-02-03 诺维信公司 天冬酰胺酶
CN102883734A (zh) * 2010-05-21 2013-01-16 Xl-蛋白有限责任公司 生物合成的脯氨酸/丙氨酸无规卷曲多肽及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
EP0206448B1 (en) 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hemoglobin combined with a poly(alkylene oxide)
GB9017002D0 (en) * 1990-08-02 1990-09-19 Health Lab Service Board Improved method for the purification of erwina l-asparaginase
WO2007103290A2 (en) 2006-03-03 2007-09-13 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Materials and methods directed to asparagine synthetase and asparaginase therapies
US8563521B2 (en) 2007-06-21 2013-10-22 Technische Universitat Munchen Biological active proteins having increased in vivo and/or in vitro stability
WO2011003633A1 (en) * 2009-07-06 2011-01-13 Alize Pharma Ii Pegylated l-asparaginase
CN104302408B (zh) 2012-02-27 2016-12-14 阿穆尼克斯运营公司 Xten缀合组合物和制造其的方法
ES2979314T3 (es) 2017-06-21 2024-09-25 Jazz Pharmaceuticals Ireland Ltd L-asparaginasa modificada

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0211639A2 (en) * 1985-08-06 1987-02-25 The Public Health Laboratory Service Board Production of L-asparaginase
CN101641439A (zh) * 2007-03-09 2010-02-03 诺维信公司 天冬酰胺酶
CN102883734A (zh) * 2010-05-21 2013-01-16 Xl-蛋白有限责任公司 生物合成的脯氨酸/丙氨酸无规卷曲多肽及其用途

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
L-Asparaginase from Erwinia Chrysanthemi 3937: Cloning, expression and characterization;Georgia A. Kotzia等;《Journal of Biotechnology》;第127卷(第4期);第657-669页,尤其是第657页左栏第1段-第658页右栏第1段 *
L-asparaginase;无;《UniProt》;无(无);P06608,参见全文 *

Also Published As

Publication number Publication date
CN111315878A (zh) 2020-06-19
JP2020528743A (ja) 2020-10-01
AU2018287145B2 (en) 2024-04-18
JP2023081915A (ja) 2023-06-13
EP3642340B1 (en) 2024-03-20
WO2018234492A1 (en) 2018-12-27
RU2020101972A3 (cg-RX-API-DMAC7.html) 2021-11-09
AU2018287145A1 (en) 2020-02-06
RU2020101972A (ru) 2021-07-21
IL271504B1 (en) 2024-01-01
MX2019015502A (es) 2020-07-28
SG11201912625QA (en) 2020-01-30
IL271504B2 (en) 2024-05-01
KR20200030065A (ko) 2020-03-19
EP4180525A1 (en) 2023-05-17
FI3642340T3 (fi) 2024-06-18
BR112019027479A2 (pt) 2020-09-15
KR102727396B1 (ko) 2024-11-08
SA519410870B1 (ar) 2023-03-06
SA522433360B1 (ar) 2024-06-23
MX2024015050A (es) 2025-01-09
JP7808424B2 (ja) 2026-01-29
IL271504A (en) 2020-02-27
JP7770352B2 (ja) 2025-11-14
ES2979314T3 (es) 2024-09-25
DK3642340T3 (da) 2024-06-03
EP3642340A1 (en) 2020-04-29
CA3068100A1 (en) 2018-12-27

Similar Documents

Publication Publication Date Title
JP7770352B2 (ja) 修飾されたl-アスパラギナーゼ
US20240076643A1 (en) Modified l-asparaginase
EP3418383A1 (en) Modified l-asparaginase
USRE49736E1 (en) Pegylated L-asparaginase
US8343760B2 (en) p53 activator peptides
EP2451486B1 (en) Pegylated l-asparaginase
WO2008145013A1 (zh) 包含cd13靶向肽和力达霉素的融合蛋白
RU2775696C2 (ru) Модифицированная l-аспарагиназа
CN108265044B (zh) 聚乙二醇定点修饰的精氨酸脱亚胺酶及其制备方法与应用
HK40090811A (en) Modified l-asparaginase
HK40029594B (en) Modified l-asparaginase
HK40029594A (en) Modified l-asparaginase

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant